An agent that activates natural killer cells and is useful in renal cell carcinoma is:
High-Yield Explanation
(Ref: Katzung 10/e p906) Recombinant IL-2 (aldesleukin) is used for the treatment of malignatn melanoma and renal cell carcinoma.